Merck, O’Reilly AlphaTech, Plug and Play, ventures capital companies, and Waters, an analytical laboratory instrument and software company, completed a $15m investment in Riffyn, a global provider of software-as-a-service for scientific process design and data analytics. “We are really pleased to lead this significant investment round alongside such high-quality co-investors and founders. Riffyn brings considerable efficiencies and value to its growing base of R&D customers worldwide. The company is becoming a stand-out leader in scientific data analytics and is a compelling example of how digital transformation is creating the lab of the future,” Joey Mason, Merck Ventures Head of Life Sciences Fund.